Three femtosecond laser comparisons: IntraLase FS30 comes out on top

Article

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

A prospective study of the three LASIK procedures was performed in 303 eyes of 167 patients. Each procedure was carried out by the same surgeon. The Hansatome XP microkeratome with 120 µm head was used on 92 eyes (Group A). The IntraLase FS2 15 Hertz laser was used to create a 120 µm flap in 100 eyes (Group B) and the IntraLase FS30 30 Hertz laser was used to create a 120 µm flap in 111 eyes (Group C). Flap thickness was measured by subtraction of intraoperative stromal pachymetry from intraoperative corneal pachymetry.

The mean flap thickness was 133.37±20.37 µm in Group A, 132.25±19.90 µm in Group B and 116.45±18.13 µm in Group C.

The researchers found that the IntraLase femtosecond FS30 created more predictable and stable flap thicknesses than the other two lasers. No significant differences were found between the Hansatome XP and the IntraLase FS2.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
© 2025 MJH Life Sciences

All rights reserved.